Yezan Munther Haddadin
Director at Outlook Therapeutics, Inc. (OTLK)
Purchase track record
Below average. Based on 2 purchases with a full 90 days of price history.
36
Avg. 90-day return-6.9%
vs. S&P 500-8.7%
Beat the market50%
Paper profit on buys−$1K
Total bought / sold$39K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 3SEC | OTLKOutlook Therapeutics, Inc. | Buy | 29,00066,167 held (+78%) | $0.83 | $24K | -27.8% |
| May 27SEC | OTLKOutlook Therapeutics, Inc. | Buy | 34,00037,167 held (+1074%) | $0.44 | $15K | +36.1% |
- Buy
Director Yezan Munther Haddadin bought $24K of OTLK at $0.83 — largest purchase by this insider in our records; raises the stake by 78%.
- Buy
Director Yezan Munther Haddadin bought $15K of OTLK at $0.44 — first open-market purchase in our records; raises the stake by 1074%.